Skip to main content
Top
Published in: BMC Pregnancy and Childbirth 1/2019

Open Access 01-12-2019 | Pre-Eclampsia | Research article

Early prediction of preeclampsia and small-for-gestational-age via multi-marker model in Chinese pregnancies: a prospective screening study

Authors: Jing Zhang, Luhao Han, Wei Li, Qiaobin Chen, Jie Lei, Min Long, Weibin Yang, Wenya Li, Lizhen Zeng, Sifan Zeng

Published in: BMC Pregnancy and Childbirth | Issue 1/2019

Login to get access

Abstract

Background

Recent evidence suggests early screening of preeclampsia and small-for-gestational-age (SGA) would benefit pregnancies followed by subsequent prophylactic use of aspirin. Multi-marker models have shown capability of predicting preeclampsia and SGA in first trimester. Yet the clinical feasibility of combined screening model for Chinese pregnancies has not been fully assessed. The aim of this study is to evaluate the applicability of a multi-marker screening model to the prediction of preeclampsia and SGA in first trimester particularly among Chinese population.

Methods

Three thousand two hundred seventy pregnancies meeting the inclusion criteria took first-trimester screening of preeclampsia and SGA. A prior risk based on maternal characteristics was evaluated, and a posterior risk was assessed by combining prior risk with multiple of median (MoM) values of mean arterial pressure (MAP), serum placental growth factor (PLGF) and pregnancy associated plasma protein A (PAPP-A). Both risks were calculated by Preeclampsia PREDICTOR™ software, Perkin Elmer. Screening performance of prior and posterior risks for early and late preeclampsia by using PREDICTOR software was shown by Receiver Operating Characteristics (ROC) curves. The estimation of detection rates and false positive rates of delivery with both preeclampsia and SGA was made.

Results

Eight cases developed early preeclampsia (0.24%) and 35 were diagnosed as late preeclampsia (1.07%). Five with early preeclampsia and ten with late preeclampsia later delivered SGA newborns (0.46%); 84 without preeclampsia gave birth to the SGAs (2.57%). According to ROC curves, posterior risks performed better than prior risks in terms of preeclampsia, especially in early preeclampsia. At 10% false positive rate, detection rates of early and late preeclampsia were 87.50 and 48.57%, detection rates of early and late SGA were 41.67 and 28.00%, respectively. For SGA, detection rates in cases with preeclampsia were much higher than those in absence of it.

Conclusions

This study demonstrates that combined screening model could be useful for predicting early preeclampsia in Chinese pregnancies. Furthermore, the performance of SGA screening by same protocol is strongly associated with preeclampsia.
Appendix
Available only for authorised users
Literature
1.
2.
go back to reference Mcintire DD, Bloom SL, Casey BM, Leveno KJ. Birth weight in relation to morbidity and mortality among newborn infants. N Engl J Med. 1999;340(16):1234–8.PubMedCrossRef Mcintire DD, Bloom SL, Casey BM, Leveno KJ. Birth weight in relation to morbidity and mortality among newborn infants. N Engl J Med. 1999;340(16):1234–8.PubMedCrossRef
3.
go back to reference Moraitis AA, Wood AM, Michael F, Smith GCS. Birth weight percentile and the risk of term perinatal death. Obstet Gynecol. 2014;124(1):274–83.PubMedCrossRef Moraitis AA, Wood AM, Michael F, Smith GCS. Birth weight percentile and the risk of term perinatal death. Obstet Gynecol. 2014;124(1):274–83.PubMedCrossRef
4.
go back to reference Wu P, Haththotuwa R, Kwok CS, Babu A, Kotronias RA, Rushton C, et al. Preeclampsia and Future Cardiovascular Health: A Systematic Review and Meta-Analysis. Circ Cardiovasc Qual Outcomes. 2017;10(2). Wu P, Haththotuwa R, Kwok CS, Babu A, Kotronias RA, Rushton C, et al. Preeclampsia and Future Cardiovascular Health: A Systematic Review and Meta-Analysis. Circ Cardiovasc Qual Outcomes. 2017;10(2).
5.
go back to reference Fields JA, Garovic VD, Mielke MM, Kantarci K, Jayachandran M, White WM, et al. Preeclampsia and cognitive impairment later in life. Am J Obstet Gynecol. 2017;217(1):74 e1–e11.CrossRef Fields JA, Garovic VD, Mielke MM, Kantarci K, Jayachandran M, White WM, et al. Preeclampsia and cognitive impairment later in life. Am J Obstet Gynecol. 2017;217(1):74 e1–e11.CrossRef
6.
go back to reference Wagner LK. Diagnosis and management of preeclampsia. Am Fam Physician. 2004;70(12):2317–24.PubMed Wagner LK. Diagnosis and management of preeclampsia. Am Fam Physician. 2004;70(12):2317–24.PubMed
7.
go back to reference Hoftiezer L, Hukkelhoven CW, Hogeveen M, Straatman HM, van Lingen RA. Defining small-for-gestational-age: prescriptive versus descriptive birthweight standards. Eur J Pediatr. 2016;175(8):1047–57.PubMedCrossRef Hoftiezer L, Hukkelhoven CW, Hogeveen M, Straatman HM, van Lingen RA. Defining small-for-gestational-age: prescriptive versus descriptive birthweight standards. Eur J Pediatr. 2016;175(8):1047–57.PubMedCrossRef
8.
go back to reference National Collaborating Centre for Women's and Children's Health (UK). Hypertension in Pregnancy: The Management of Hypertensive Disorders During Pregnancy. London: RCOG Press; 2010 Aug. (NICE Clinical Guidelines, No. 107.) National Collaborating Centre for Women's and Children's Health (UK). Hypertension in Pregnancy: The Management of Hypertensive Disorders During Pregnancy. London: RCOG Press; 2010 Aug. (NICE Clinical Guidelines, No. 107.)
9.
go back to reference No CO. 638: first-trimester risk assessment for early-onset preeclampsia. Obstet Gynecol. 2015;126(3):e25–7.CrossRef No CO. 638: first-trimester risk assessment for early-onset preeclampsia. Obstet Gynecol. 2015;126(3):e25–7.CrossRef
10.
go back to reference Sung KU, Roh JA, Eoh KJ, Kim EH. Maternal serum placental growth factor and pregnancy-associated plasma protein a measured in the first trimester as parameters of subsequent pre-eclampsia and small-for-gestational-age infants: a prospective observational study. Obstet Gynecol Sci. 2017;60(2):154–62.PubMedPubMedCentralCrossRef Sung KU, Roh JA, Eoh KJ, Kim EH. Maternal serum placental growth factor and pregnancy-associated plasma protein a measured in the first trimester as parameters of subsequent pre-eclampsia and small-for-gestational-age infants: a prospective observational study. Obstet Gynecol Sci. 2017;60(2):154–62.PubMedPubMedCentralCrossRef
11.
go back to reference Nucci M, Poon LC, Demirdjian G, Darbouret B, Nicolaides KH. Maternal serum placental growth factor (PlGF) isoforms 1 and 2 at 11-13 weeks’ gestation in normal and pathological pregnancies. Fetal Diagn Ther. 2014;36(2):106–16.PubMedCrossRef Nucci M, Poon LC, Demirdjian G, Darbouret B, Nicolaides KH. Maternal serum placental growth factor (PlGF) isoforms 1 and 2 at 11-13 weeks’ gestation in normal and pathological pregnancies. Fetal Diagn Ther. 2014;36(2):106–16.PubMedCrossRef
12.
go back to reference Wright D, Akolekar R, Syngelaki A, Poon LC, Nicolaides KH. A competing risks model in early screening for preeclampsia. Fetal Diagn Ther. 2012;32(3):171–8.PubMedCrossRef Wright D, Akolekar R, Syngelaki A, Poon LC, Nicolaides KH. A competing risks model in early screening for preeclampsia. Fetal Diagn Ther. 2012;32(3):171–8.PubMedCrossRef
13.
go back to reference Akolekar R, Syngelaki A, Poon L, Wright D, Nicolaides KH. Competing risks model in early screening for preeclampsia by biophysical and biochemical markers. Fetal Diagn Ther. 2013;33(1):8–15.PubMedCrossRef Akolekar R, Syngelaki A, Poon L, Wright D, Nicolaides KH. Competing risks model in early screening for preeclampsia by biophysical and biochemical markers. Fetal Diagn Ther. 2013;33(1):8–15.PubMedCrossRef
14.
go back to reference Tan MY, Wright D, Syngelaki A, Akolekar R, Cicero S, Janga D, et al. Comparison of diagnostic accuracy of early screening for pre-eclampsia by NICE guidelines and a method combining maternal factors and biomarkers: results of SPREE. Ultrasound Obstet Gynecol. 2018;51(6):742-50.CrossRef Tan MY, Wright D, Syngelaki A, Akolekar R, Cicero S, Janga D, et al. Comparison of diagnostic accuracy of early screening for pre-eclampsia by NICE guidelines and a method combining maternal factors and biomarkers: results of SPREE. Ultrasound Obstet Gynecol. 2018;51(6):742-50.CrossRef
15.
go back to reference O'Gorman N, Wright D, Poon LC, Rolnik DL, Syngelaki A, De AM, et al. Multicenter screening for preeclampsia by maternal factors and biomarkers at 11–13 weeks’ gestation: comparison to NICE guidelines and ACOG recommendations. Ultrasound Obstet Gynecol. 2017;49(6):756.CrossRef O'Gorman N, Wright D, Poon LC, Rolnik DL, Syngelaki A, De AM, et al. Multicenter screening for preeclampsia by maternal factors and biomarkers at 11–13 weeks’ gestation: comparison to NICE guidelines and ACOG recommendations. Ultrasound Obstet Gynecol. 2017;49(6):756.CrossRef
16.
go back to reference Poon LC, Syngelaki A, Akolekar R, Lai J, Nicolaides KH. Combined screening for preeclampsia and small for gestational age at 11-13 weeks. Fetal Diagn Ther. 2013;33(1):16–27.PubMedCrossRef Poon LC, Syngelaki A, Akolekar R, Lai J, Nicolaides KH. Combined screening for preeclampsia and small for gestational age at 11-13 weeks. Fetal Diagn Ther. 2013;33(1):16–27.PubMedCrossRef
17.
go back to reference O'Gorman N, Wright D, Poon LC, Rolnik DL, Syngelaki A, Wright A, et al. Accuracy of competing-risks model in screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks’ gestation. Ultrasound Obstet Gynecol. 2017;49(6):751–5.PubMedCrossRef O'Gorman N, Wright D, Poon LC, Rolnik DL, Syngelaki A, Wright A, et al. Accuracy of competing-risks model in screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks’ gestation. Ultrasound Obstet Gynecol. 2017;49(6):751–5.PubMedCrossRef
18.
go back to reference Mosimann B, Pfiffner C, Amylidi-Mohr S, Risch L, Surbek D, Raio L. First trimester combined screening for preeclampsia and small for gestational age - a single Centre experience and validation of the FMF screening algorithm. Swiss Med Wkly. 2017;147:w14498.PubMed Mosimann B, Pfiffner C, Amylidi-Mohr S, Risch L, Surbek D, Raio L. First trimester combined screening for preeclampsia and small for gestational age - a single Centre experience and validation of the FMF screening algorithm. Swiss Med Wkly. 2017;147:w14498.PubMed
19.
go back to reference Guizani M, Valsamis J, Dutemeyer V, Kang X, Ceccoti V, Khalife J, et al. First-trimester combined multimarker prospective study for the detection of pregnancies at a high risk of developing preeclampsia using the Fetal Medicine Foundation-algorithm. Fetal Diagnosis & Therapy. 2017;110(6):399. Guizani M, Valsamis J, Dutemeyer V, Kang X, Ceccoti V, Khalife J, et al. First-trimester combined multimarker prospective study for the detection of pregnancies at a high risk of developing preeclampsia using the Fetal Medicine Foundation-algorithm. Fetal Diagnosis & Therapy. 2017;110(6):399.
20.
go back to reference Skrastad RB, Hov GG, Blaas HG, Romundstad PR, Salvesen KA. Risk assessment for preeclampsia in nulliparous women at 11-13 weeks gestational age: prospective evaluation of two algorithms. BJOG. 2015;122(13):1781–8.PubMedCrossRef Skrastad RB, Hov GG, Blaas HG, Romundstad PR, Salvesen KA. Risk assessment for preeclampsia in nulliparous women at 11-13 weeks gestational age: prospective evaluation of two algorithms. BJOG. 2015;122(13):1781–8.PubMedCrossRef
21.
go back to reference Cuckle HS. Screening for pre-eclampsia--lessons from aneuploidy screening. Placenta. 2011;32(Suppl):S42–8.PubMedCrossRef Cuckle HS. Screening for pre-eclampsia--lessons from aneuploidy screening. Placenta. 2011;32(Suppl):S42–8.PubMedCrossRef
22.
go back to reference Poon LCY, Zymeri NA, Zamprakou A, Syngelaki A, Nicolaides KH. Protocol for measurement of mean arterial pressure at 11-13 Weeks’ gestation. Fetal Diagnosis & Therapy. 2012;31(1):42.CrossRef Poon LCY, Zymeri NA, Zamprakou A, Syngelaki A, Nicolaides KH. Protocol for measurement of mean arterial pressure at 11-13 Weeks’ gestation. Fetal Diagnosis & Therapy. 2012;31(1):42.CrossRef
23.
go back to reference Zi Y. Zhang W-y. guidelines for the diagnosis and treatment of hypertensive disorders in pregnancy (2015). Chinese Journal of Obstetrics and Gynecology. 2015;50(10):721–8. Zi Y. Zhang W-y. guidelines for the diagnosis and treatment of hypertensive disorders in pregnancy (2015). Chinese Journal of Obstetrics and Gynecology. 2015;50(10):721–8.
24.
go back to reference Tranquilli AL, Dekker G, Magee L, Roberts J, Sibai BM, Steyn W, et al. The classification, diagnosis and management of the hypertensive disorders of pregnancy: a revised statement from the ISSHP. Pregnancy Hypertension An International Journal of Womens Cardiovascular Health. 2014;4(2):97–104. Tranquilli AL, Dekker G, Magee L, Roberts J, Sibai BM, Steyn W, et al. The classification, diagnosis and management of the hypertensive disorders of pregnancy: a revised statement from the ISSHP. Pregnancy Hypertension An International Journal of Womens Cardiovascular Health. 2014;4(2):97–104.
25.
go back to reference Zhu L, Zhang R, Zhang S, Shi W, Yan W, Wang X, et al. Chinese neonatal birth weight curve for different gestational age. Zhonghua Er Ke Za Zhi. 2015;53(2):97–103.PubMed Zhu L, Zhang R, Zhang S, Shi W, Yan W, Wang X, et al. Chinese neonatal birth weight curve for different gestational age. Zhonghua Er Ke Za Zhi. 2015;53(2):97–103.PubMed
26.
go back to reference Zhong Y, Zhu F, Ding Y. Serum screening in first trimester to predict pre-eclampsia, small for gestational age and preterm delivery: systematic review and meta-analysis. BMC Pregnancy Childbirth. 2015;15:191 Zhong et al.PubMedPubMedCentralCrossRef Zhong Y, Zhu F, Ding Y. Serum screening in first trimester to predict pre-eclampsia, small for gestational age and preterm delivery: systematic review and meta-analysis. BMC Pregnancy Childbirth. 2015;15:191 Zhong et al.PubMedPubMedCentralCrossRef
27.
go back to reference Sonek J, Krantz D, Carmichael J, Downing C, Jessup K, Haidar Z, et al. First trimester screening for early and late preeclampsia using maternal characteristics, biomarkers, and estimated placental volume. Am J Obstet Gynecol. 2017;218(1):S0002937817312176. Sonek J, Krantz D, Carmichael J, Downing C, Jessup K, Haidar Z, et al. First trimester screening for early and late preeclampsia using maternal characteristics, biomarkers, and estimated placental volume. Am J Obstet Gynecol. 2017;218(1):S0002937817312176.
28.
go back to reference O'Gorman N, Wright D, Syngelaki A, Akolekar R, Wright A, Poon LC, et al. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11–13 weeks gestation. Am J Obstet Gynecol. 2016;214(1):103.e1–e12.CrossRef O'Gorman N, Wright D, Syngelaki A, Akolekar R, Wright A, Poon LC, et al. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11–13 weeks gestation. Am J Obstet Gynecol. 2016;214(1):103.e1–e12.CrossRef
29.
go back to reference Crovetto F, ., Crispi F, ., Scazzocchio E, ., Mercade I, ., Meler E, ., Figueras F, ., et al. First-trimester screening for early and late small-for-gestational-age neonates using maternal serum biochemistry, blood pressure and uterine artery Doppler. Ultrasound in Obstetrics & Gynecology the Official Journal of the International Society of Ultrasound in Obstetrics & Gynecology 2014;43(1):34–40.CrossRef Crovetto F, ., Crispi F, ., Scazzocchio E, ., Mercade I, ., Meler E, ., Figueras F, ., et al. First-trimester screening for early and late small-for-gestational-age neonates using maternal serum biochemistry, blood pressure and uterine artery Doppler. Ultrasound in Obstetrics & Gynecology the Official Journal of the International Society of Ultrasound in Obstetrics & Gynecology 2014;43(1):34–40.CrossRef
30.
go back to reference Bilano VL, Ota E, Ganchimeg T, Mori R, Souza JP. Risk factors of pre-eclampsia/eclampsia and its adverse outcomes in low- and middle-income countries: a WHO secondary analysis. PLoS One. 2014;9(3):e91198.PubMedPubMedCentralCrossRef Bilano VL, Ota E, Ganchimeg T, Mori R, Souza JP. Risk factors of pre-eclampsia/eclampsia and its adverse outcomes in low- and middle-income countries: a WHO secondary analysis. PLoS One. 2014;9(3):e91198.PubMedPubMedCentralCrossRef
31.
go back to reference O'Gorman N, Tampakoudis G, Wright A, Wright D, Nicolaides KH. Uterine artery pulsutility index at 12, 22, 32 and 36 weeks’ gestation in screening for preeclampsia. Ultrasound in Obstetrics & Gynecology the Official Journal of the International Society of Ultrasound in Obstetrics & Gynecology. 2016;47(5):565–72.CrossRef O'Gorman N, Tampakoudis G, Wright A, Wright D, Nicolaides KH. Uterine artery pulsutility index at 12, 22, 32 and 36 weeks’ gestation in screening for preeclampsia. Ultrasound in Obstetrics & Gynecology the Official Journal of the International Society of Ultrasound in Obstetrics & Gynecology. 2016;47(5):565–72.CrossRef
32.
go back to reference Nicolaides KH. Turning the pyramid of prenatal care. Fetal Diagnosis & Therapy. 2011;29(3):183–96.CrossRef Nicolaides KH. Turning the pyramid of prenatal care. Fetal Diagnosis & Therapy. 2011;29(3):183–96.CrossRef
33.
go back to reference Stéphanie R, Yves G, Pia V, Kypros N, Merja V, Jean-Claude F, et al. Early administration of low-dose aspirin for the prevention of severe and mild preeclampsia: a systematic review and meta-analysis. Am J Perinatol. 2012;31(3):141–6. Stéphanie R, Yves G, Pia V, Kypros N, Merja V, Jean-Claude F, et al. Early administration of low-dose aspirin for the prevention of severe and mild preeclampsia: a systematic review and meta-analysis. Am J Perinatol. 2012;31(3):141–6.
34.
go back to reference Roberge S, Nicolaides K, Demers S, Hyett J, Chaillet N, Bujold E. The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis. Am J Obstet Gynecol. 2016;216(2):110–20.PubMedCrossRef Roberge S, Nicolaides K, Demers S, Hyett J, Chaillet N, Bujold E. The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis. Am J Obstet Gynecol. 2016;216(2):110–20.PubMedCrossRef
35.
go back to reference Rolnik DL, Wright D, Poon LC, O'Gorman N, Syngelaki A, De PMC, et al. Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia. N Engl J Med. 2017;73(7):613–22.CrossRef Rolnik DL, Wright D, Poon LC, O'Gorman N, Syngelaki A, De PMC, et al. Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia. N Engl J Med. 2017;73(7):613–22.CrossRef
36.
go back to reference Wright D, Rolnik DL, Syngelaki A, Matallana CDP, Machuca M, Alvarado MD, et al. Aspirin for evidence-based preeclampsia prevention trial: effect of aspirin on length of stay in the neonatal intensive care unit. Am J Obstet Gynecol. 2018;218(6):612.e1-612.e6.PubMedCrossRef Wright D, Rolnik DL, Syngelaki A, Matallana CDP, Machuca M, Alvarado MD, et al. Aspirin for evidence-based preeclampsia prevention trial: effect of aspirin on length of stay in the neonatal intensive care unit. Am J Obstet Gynecol. 2018;218(6):612.e1-612.e6.PubMedCrossRef
37.
go back to reference Tan MY, Poon LC, Rolnik DL, Syngelaki A, de Paco MC, Akolekar R, et al. Prediction and prevention of small-for-gestational-age neonates: evidence from SPREE and ASPRE. Ultrasound Obstet Gynecol. 2018;52(1):52–9.PubMedCrossRef Tan MY, Poon LC, Rolnik DL, Syngelaki A, de Paco MC, Akolekar R, et al. Prediction and prevention of small-for-gestational-age neonates: evidence from SPREE and ASPRE. Ultrasound Obstet Gynecol. 2018;52(1):52–9.PubMedCrossRef
38.
go back to reference Changxiu L. Effect of low-dose aspirin on prevention of eclampsia and preeclampsia in elderly (high-risk) pregnancy and its effect on pregnancy outcome. THE JOURNAL OF MEDICAL THEORY AND PRACTICE. 2017;23:3472–4. Changxiu L. Effect of low-dose aspirin on prevention of eclampsia and preeclampsia in elderly (high-risk) pregnancy and its effect on pregnancy outcome. THE JOURNAL OF MEDICAL THEORY AND PRACTICE. 2017;23:3472–4.
39.
go back to reference Lin L, Zhu Y, Li B, Yang H, Group AS. Low-dose aspirin in the prevention of pre-eclampsia in China (APPEC study): protocol for a multicentre randomized controlled trial. Trials. 2018;19(1):608.PubMedPubMedCentralCrossRef Lin L, Zhu Y, Li B, Yang H, Group AS. Low-dose aspirin in the prevention of pre-eclampsia in China (APPEC study): protocol for a multicentre randomized controlled trial. Trials. 2018;19(1):608.PubMedPubMedCentralCrossRef
Metadata
Title
Early prediction of preeclampsia and small-for-gestational-age via multi-marker model in Chinese pregnancies: a prospective screening study
Authors
Jing Zhang
Luhao Han
Wei Li
Qiaobin Chen
Jie Lei
Min Long
Weibin Yang
Wenya Li
Lizhen Zeng
Sifan Zeng
Publication date
01-12-2019
Publisher
BioMed Central
Keyword
Pre-Eclampsia
Published in
BMC Pregnancy and Childbirth / Issue 1/2019
Electronic ISSN: 1471-2393
DOI
https://doi.org/10.1186/s12884-019-2455-8

Other articles of this Issue 1/2019

BMC Pregnancy and Childbirth 1/2019 Go to the issue